The missing piece in post-transplant bone health: tertiary hyperparathyroidism management
Saved in:
| Main Authors: | Burçak Cavnar Helvacı, Özant Helvacı |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-07-01
|
| Series: | Therapeutic Advances in Endocrinology and Metabolism |
| Online Access: | https://doi.org/10.1177/20420188251359790 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Concerns Regarding Renal Function Claims in Low‐Dose Spironolactone Study
by: Özant Helvacı, et al.
Published: (2025-07-01) -
Challenging the Restrictive Approach: Reconsidering Sodium-Glucose Transport Protein 2 Inhibitor Use in CKD
by: Ozant Helvaci, et al.
Published: (2024-06-01) -
Using cinacalcet in the treatment of post-transplantation tertiary hyperparathyroidism: a report of two cases
by: Xiang Hua, et al.
Published: (2021-01-01) -
Concurrent extramedullary hematopoiesis and AA amyloidosis in the kidney
by: Özant Helvaci, et al.
Published: (2025-03-01) -
Nephrological perspectives on the underutilization of SGLT2is in heart failure and chronic kidney disease
by: Özant Helvacı, et al.
Published: (2025-04-01)